KRRO Korro Bio, Inc.
$13.86▲ +4.21%
Healthcare
Other
After hours
$13.88▲ +0.14%
Oct 28, 6:56 PM ET
Volume 269.0K
Avg Volume (10D) 248.8K
Key Metrics & Fundamentals
Market Cap
$204.10M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.20 - 42.70
% vs 50 MA
21.90%
% vs 200 MA
16.69%
RSI-14
70.4
MACD Histogram
+0.5900
Beta (1Y vs SPY)
2.47
Free Cash Flow
-$17.03M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$19.75M
COGS
–
Operating Exp
$20.11M
Operating Income
-$20.11M
EBIT
-$20.11M
Pretax Income
-$18.81M
Net Income
-$18.92M
EPS (Diluted)
-1.07
Price & Volume History
Loading chart…
Recent News
Korro Bio, Inc. (KRRO) Surges 29.7%: Is This an Indication of Further Gains?
Zacks · Oct 23, 2026 5:47 AM ET
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
GlobeNewswire · Oct 22, 2026 7:00 AM ET
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 16, 2026 4:05 PM ET
Korro Bio Says First Participants Dosed in KRRO-121 Trial
MT Newswires · Oct 5, 2026 5:14 PM ET
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 11, 2026 4:05 PM ET
Korro to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 27, 2026 7:00 AM ET
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 14, 2026 4:05 PM ET
All You Need to Know About Korro Bio, Inc. (KRRO) Rating Upgrade to Buy
Zacks · Aug 10, 2026 12:00 PM ET
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 6, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See KRRO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.